When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.
Be alerted of any news about your stocks and see what other stocks are trending.
ONCT - Oncternal Therapeutics' lead drug shows positive effect in blood cancer
Oncternal Therapeutics Inc.
Preliminary results from a Phase 1/2 clinical trial evaluating Oncternal Therapeutics' (ONCT+4.3%) lead candidate cirmtuzumab, combined with AbbVie and J&J's Imbruvica (ibrutinib), in blood cancer patients showed encouraging action in a subset of participants with relapsed/refractory mantle cell lymphoma (MCL).
More news on: Oncternal Therapeutics, Inc., Healthcare stocks news, Stocks on the move,